Proofstock
DashboardScreenerTrack RecordMethodology
DashboardScreenerTrack RecordMethodology
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

Proofstock
DashboardScreenerTrack RecordMethodology
As of
July 13, 2026
DashboardScreenerTrack RecordMethodology
← Dashboard

BEAM

Neutral

Beam Therapeutics Inc.

Healthcare · Biotechnology · $2.87B market cap

Last close
$31.00
-5.14% · 1 day
as of Jul 13, 2026
60-day price history
Rating
Neutral44thpercentile
Ranks #105 of 194 in Healthcare

Sits near the middle of the universe on the composite score. Ranks in the 44th percentile overall.

Factor breakdown

Momentum
Quality
Value
Growth
Size
Low Volatility

What this stock is good at

Nothing notable on this side.

What this stock is not strong at

Nothing notable on this side.

Rating history

Last 27 scored days
Proofstock
DashboardScreenerTrack RecordMethodology

Proofstock provides quantitative ratings and research based on a transparent six-factor methodology. These ratings are research products, not investment recommendations. We are not a Registered Investment Advisor, and nothing on this site constitutes personalized investment advice. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.

May 17, 2026 · 37thJul 13, 2026 · 44th

Recent factor inputs

The latest raw values feeding the six factors.

P/E
-6.5×
P/B
2.1×
EV/EBITDA
-27.3×
FCF yield
—
ROE
-8.1%
ROIC
-7.5%
Debt / equity
0.22
Rev growth 3Y
158.0%
EPS growth 3Y
85.3%
12-1 return
33.9%
3M return
13.0%
Realized vol
73.5%